Skip to content

Comparison of the Brainstim tDCS stimulator versus the neuroconn tDCS stimulator in terms of effiency and comfort

Comparison of the Brainstim tDCS stimulator versus the neuroconn tDCS stimulator in terms of effiency and comfort - Brainstim versus neuroconn

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00003602
Enrollment
15
Registered
2012-03-09
Start date
2012-05-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteers

Interventions

Group 1: cephalic stimulation with the neuroconn stimulator, active condition Group 2: cephalic stimulation with the neuroconn stimulator, sham condition Group 3: cephalic stimulation with the brainst

Sponsors

Klinik für Psychiatrie, Psychotherapie und Psychosomatik
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: healthy subjects

Exclusion criteria

Exclusion criteria: neurologic, psychiatric, internal, dermatologic disorders, obesity.

Design outcomes

Primary

MeasureTime frame
End point is the completion of four different treatment conditions for comparison of comfort and efficiency due to the single measures. Stimulations take place with a minimum 24 h interval, measures are immediately after stimulation. Each volunteer has to assess uncomfortable side effects of the stimulation with the Comfort Rating Questionnaire. Additionally EEG recording is performed at baseline before first stimulation and after each stimulation. Aim is to show similar effects of both stimulators in terms of comfortability of active and sham stimulation and the documentation of the same activation of deep brain regions by both stimulators, measured by EEG-LORETA.

Countries

Germany

Contacts

Public ContactUlrich Palm

Klinik für Psychiatrie, Psychotherapie und Psychosomatik

ulrich.palm@med.uni-muenchen.de089/5160-5511

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026